πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 738 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10927124

Compounds and compositions and uses thereof

PGI Drug Discovery LLC Β· Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10913753

Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

Valo Early Discovery, Inc. Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10906916

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

Valo Early Discovery, Inc. Β· Granted Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10894033

Multicyclic compounds and methods of use thereof

PGI Drug Discovery LLC Β· Granted Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10894786

Substituted pyrazole derivatives as selective CDK12/13 inhibitors

Aurigene Discovery Technologies Limited Β· Granted Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10889592

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

Valo Early Discovery, Inc. Β· Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10889576

Phthalazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC Β· Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10881646

Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

Biomed Valley Discoveries, Inc. Β· Granted Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10874649

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

Valo Early Discovery, Inc. Β· Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10870645

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

Valo Early Discovery, Inc. Β· Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10864217

Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10858436

PSGL-1 modulators and uses thereof

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10851112

Anti-HCMV virus compound

Medshine Discovery Inc. Β· Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10836741

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Valo Early Discovery, Inc. Β· Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10836728

Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using

Mebias Discovery, Inc. Β· Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10829462

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Valo Early Discovery, Inc. Β· Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10829460

[6,6] fused bicyclic HDAC8 inhibitors

Valo Early Discovery, Inc. Β· Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10829461

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Valo Early Discovery, Inc. Β· Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10822316

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Valo Early Discovery, Inc. Β· Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10808004

Triterpene-glycoside as sweetener or sweetener enhancer

Analyticon Discovery GmbH Β· Granted Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10781189

1,2,4-Oxadiazole and thiadiazole compounds as immunomodulators

Aurigene Discovery Technologies Limited Β· Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10780074

Compounds and uses thereof

PGI Drug Discovery LLC Β· Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10774092

ULK1 inhibitors and methods using same

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10766902

Wee-1 inhibiting pyrazolopyrimidinone compounds

ALMAC DISCOVERY LIMITED Β· Granted Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted